Relationship between polymorphisms of renin-angiotensin system gene and pressure-lowering response to irbesartan treatment in hypertension patients

王鲁雁,闫征,王鸿懿,孙宁玲

DOI: https://doi.org/10.3969/j.issn.1671-6272.2004.03.002

2004-01-01

Abstract:Objective To determine whether polymorphisms in the renin-angiotensin system can predict blood pressure-lowing response to angiotensinⅡreceptor type 1 antagonist treatment,specifically,in response to treatment with irbesartan.Methods 117 Patients with mild to moderate essential hypertension diagnosted according to the criteria of hypertension of WHO/ISH were enrolled in and treated with irbesartan for 8 weeks.We analysed polymorphisms:angiotensin converting enzyne insertion/deletion (ACE I/D),angiotensinogen M235T(AGT M235T),angiotensin Ⅱ type 1 receptor 1166A/C?573 T/C?1062 A/G?-521 C/T and related them to blood pressure reduction.Results Individuals with the ACE gene D allele showed a greater reduction in systolic blood pressure than those homozygous for I allele (16.65±12.81 versus 11.98±10.17 mmHg,P=0.046).Individuals with the AT1R 573 T allele showed a greater reduction in systolic blood pressure than those homozygous for Callele (16.65±12.81 versus 11.98±10.17 mmHg,P=0.046).The angiotensinogen M235T?AT1R 1166A/C?-521 C/T was not related to the response to treatment.was not related to the response to treatment.Conclusion ACE I/D and AT1R 573 T/C genotyping was related with the blood pressure-lowering response to antihypertensive treatment with irbesartan.